Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05000866 · ClinicalTrials.gov registry record · NA

Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples

A NA study of HIV Infections and Substance Use, sponsored by Hunter College of City University of New York.

Active
Registry status
NA
Development phase
484
Enrollment target
2
Study locations

NCT05000866: Active NA study of HIV Infections and Substance Use, sponsored by Hunter College of City University of New York.

NCT05000866 is a NA study of HIV Infections and Substance Use that is active but no longer recruiting, run by Hunter College of City University of New York. The registered enrollment target is 484 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05000866, a NA study of HIV Infections and Substance Use, is active but no longer recruiting, sponsored by Hunter College of City University of New York.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
484 participants
Enrollment target
2
Study locations

Study Summary

This study utilizes a randomized controlled trial design to evaluate the efficacy of two intervention components for couples HIV testing and counseling (CHTC): a communication skills training video and a substance use module. Participants are randomized in a full-factorial design to one of 4 conditions: CHTC as usual; CHTC + communication skills training videos; CHTC + substance use module; or CHTC plus both adjunct components.

Primary Outcome

Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments

Interventions

  • BEHAVIORAL Communication skills training video
  • BEHAVIORAL Drug use module

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

New York

  • Hunter College - New York

Trial Details

FieldValue
Enrollment Target 484 participants
Start Date 2021-10-13
Est. Completion 2026-05-31
Phase NA

What the registry record for NCT05000866 still lists

NCT05000866 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Communication skills training video is the first listed.

NCT05000866 reports a single indexed study location in Michigan, New York.

Frequently Asked Questions

What is clinical trial NCT05000866 about?

NCT05000866 is a clinical study titled "Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples". This study utilizes a randomized controlled trial design to evaluate the efficacy of two intervention components for couples HIV testing and counseling (CHTC): a communication skills training video and a substance use module. Participants are randomized in a full-factorial design to one of 4 conditi...

What is the current status of trial NCT05000866?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 484 participants. The study started on 2021-10-13. Estimated completion is 2026-05-31.

What conditions does trial NCT05000866 study?

This clinical trial studies the following conditions: HIV Infections, Substance Use.

What interventions are being tested in trial NCT05000866?

The interventions under investigation include: Communication skills training video (BEHAVIORAL), Drug use module (BEHAVIORAL).

Who is sponsoring clinical trial NCT05000866?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05000866 being conducted?

This trial has 2 study locations across Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05000866's enrollment target sits among peer trials

484 67th of 542 higher than 476 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

  • NCT07124910 · 485 participants · Phase 3

    Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05000866, the US trial registry maintained by the National Library of Medicine. NCT05000866 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.